Neuromodulation/Neurostimulation
Ex-sales rep sues Medtronic, claims she was fired for blowing the whistle
FDA seeks additional trial on Zalviso drug-device combo from AcelRx
(Reuters) — AcelRx Pharmaceuticals (NSDQ:ACRX) said the FDA wants an additional study on its Zalviso drug-device combination, which the safety watchdog already rejected once last year.
UPDATE: Cyberonics to buy Italy’s Sorin for $1.4B
FDA clears Bioness’ StimRouter device for chronic pain
The FDA has granted market clearance for Bioness' Stimrouter for the treatment of chronic peripheral pain.
The company describes StimRouter as a minimally invasive, implanted neuromodulation device that sends electrical signals to the pain's point of origin. The device is controlled by a wireless, hand-held unit.
Medtronic settles another whistleblower suit for $2.8m
Nevro surges on Senza approvable letter from FDA
Medtronic wins HDE for Enterra II neurostim device
Weight loss: FDA approves EnteroMedics Maestro obesity device
Hypertension: CVRx wins FDA nod for Barostim neo legacy
Stimwave Technologies launches new chronic pain trial for mini neurostim device
Stimwave Technologies said it’s launching a new clinical trial for its miniature, wireless neuromodulation anti-pain device for treating chronic, non-specific-origin lower back pain.